Related Experiment Video

Updated: Feb 10, 2026

Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells
14:37

Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells

Published on: November 1, 2017

11.8K

Endothelial Progenitor Cells in Heart Failure: an Authentic Expectation for Potential Future Use and a Lack of

Andie H Djohan1, Ching-Hui Sia2, Poay Sian Lee3

  • 1Department of Medicine, National University Health System, Singapore, Singapore.

Journal of Cardiovascular Translational Research
|May 20, 2018
PubMed

Insights

Endothelial progenitor cells (EPCs) help maintain healthy blood vessels and protect the heart. This study explores their role in congestive heart failure (CHF) and their potential as a therapy.

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Cellular Biology

Background:

  • Congestive heart failure (CHF) is a widespread condition with significant mortality.
  • Cardiac fibrosis and remodeling due to cardiomyocyte loss characterize CHF.
  • Endothelial progenitor cells (EPCs) are crucial for vascular integrity and myocardial protection.

Purpose of the Study:

  • To define EPCs and their function in both healthy and CHF states.
  • To investigate the role of EPCs in CHF pathophysiology and prognosis.
  • To explore the therapeutic potential and clinical limitations of EPCs for CHF.

Main Methods:

  • Literature review and synthesis of existing research on EPCs.
  • Analysis of EPC behavior in the context of CHF.
  • Discussion of clinical applications and restrictions.

Main Results:

  • EPCs contribute to endothelial health through vasculogenesis and angiogenesis.
  • EPC function and relevance in CHF pathophysiology are explored.
  • Prognostic significance and therapeutic potential of EPCs in CHF are highlighted.

Conclusions:

  • EPCs play a vital role in maintaining vascular health and protecting the heart.
  • Understanding EPC behavior in CHF is crucial for developing new therapies.
  • Further research is needed to overcome clinical restrictions for EPC-based treatments.

Keywords:
Congestive heart failureEndothelial dysfunctionEndothelial progenitor cells

More Related Videos

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery08:43

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Published on: February 14, 2017

11.5K
Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions12:48

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Published on: January 7, 2019

6.8K

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
993
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.9K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
947
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
391
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
356